文献速递自身炎症与 IgG4 相关病

人附睾蛋白4(HE4)是IgG4相关性疾病纤维化的新型生物标志物并可预测不良预后

Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis.
PubMed 文献 · RMD Open · 2022-01-01

本研究纳入136例IgG4相关性疾病患者和73名健康对照,检测血浆HE4水平并行组织免疫组化和Masson三色染色,发现患者HE4显著高于对照,最佳截断值50.8 pmol/L对应AUC 0.791,HE4与多种实验室指标及器官功能损伤正相关,与纤维化程度密切相关,HE4高表达组预后不良。

要点

  • IgG4-RD患者血浆HE4显著高于健康对照,鉴别最佳截断值50.8 pmol/L,AUC 0.791。
  • HE4与多种实验室参数及器官功能损伤指标正相关,并与受累器官纤维化程度密切相关。
  • HE4高表达组患者预后不良。

核心结论

  • HE4可作为IgG4-RD的生物标志物,与多种基线临床特征、内脏器官损伤及受累器官纤维化程度相关,并能预测不良预后。

研究设计与样本

  • 研究检测136例IgG4-RD患者和73名健康对照的血浆HE4水平,采用电化学发光法。
  • 对15例IgG4-RD患者和10名对照的胰腺组织,采用免疫组化和Masson三色染色比较HE4表达水平及纤维化程度。
  • 研究分析HE4与实验室参数的相关性,并评估HE4作为IgG4-RD纤维化和预后生物标志物的效能。

主要发现

  • IgG4-RD患者血浆HE4水平显著高于健康对照。
  • 鉴别IgG4-RD患者的最佳HE4截断值为50.8 pmol/L,AUC为0.791。
  • HE4水平与多种实验室参数及器官功能损伤指标呈正相关。
  • HE4在IgG4-RD患者受累器官中高表达,其血浆水平与纤维化程度密切相关。
  • HE4高表达组患者预后不良。

关键数值与推荐

  • 鉴别IgG4-RD患者的最佳HE4截断值为50.8 pmol/L,AUC为0.791。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: IgG4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory disorder with heterogeneous manifestations. This study aimed to investigate the utility of human epididymis protein 4 (HE4) as a potential clinical biomarker of fibrosis in IgG4-RD. METHODS: Plasma HE4 levels were estimated in 136 patients with IgG4-RD and 73 healthy individuals (controls) by electrochemical luminescence. HE4 expression levels and the degree of fibrosis in pancreatic tissues from 15 patients with IgG4-RD and 10 controls were compared using immunohistochemistry and Masson trichrome staining. Correlation between HE4 levels and laboratory parameters was determined, and the efficacy of HE4 as a biomarker of fibrosis and prognosis in IgG4-RD was also evaluated. RESULTS: Plasma HE4 levels were significantly higher in patients with IgG4-RD compared with controls. Optimal HE4 cut-off value for identifying patients with IgG4-RD was determined to be 50.8 pmol/L with an AUC (area under curve) of 0.791. HE4 levels were positively correlated with diverse laboratory parameters, and indicators of organ function impairment. Additionally, HE4 was highly expressed in the affected organs in patients with IgG4-RD and its plasma levels were closely correlated with degree of fibrosis, indicating the utility of HE4 in assessing internal organ damage and fibrosis. Further analysis showed that patients in the HE4 high expression group had poor prognosis. CONCLUSIONS: Our results demonstrate that HE4 can be used as a biomarker for IgG4-RD as it is correlated with diverse baseline clinical features, internal organ damage and degree of fibrosis in affected organs, and can predict poor prognosis.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Yan S, Peng Y, Wu Z, et al. Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis. RMD Open. 2022. PMID: 36167476. doi:10.1136/rmdopen-2022-002521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。